XML 69 R50.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of assumptions used to estimate the fair values of the share options granted

For the year ended December 31,

 

    

2021

    

2022

    

2023

 

Expected volatility

48.00% - 74.00

%

74.00% – 80.00

%

82.00% - 85.00

%

Risk-free interest rate (per annum)

0.97% - 1.55

%

1.94% – 3.83

%

3.57% - 4.47

%

Expected dividend yield

0.00

%

0.00

%

0.00

%

Employee forfeiture rate (per annum)

3.80

%

3.80% – 3.92

%

2.40% - 7.50

%

Exercise multiples

2.50

2.50

2.50

Expected term

7.00

7.00

7.00

Fair value of underlying ordinary share (per share)

US$14.10 - 18.42

US$18.11 – 19.91

US$7.95 - 15.47

Fair value of awards on valuation date

US$5.84 - 19.90

US$12.93 – 17.11

US$5.38 - 10.51

Schedule of stock option activity

Weighted

Weighted

Weighted

average

Number

average

average

remaining

Aggregate

of

exercise

grant date

contract

intrinsic

options

price

fair value

life

value

    

    

RMB

    

RMB

    

Years

    

    RMB

Outstanding at December 31, 2022

9,608,634

12.51

65.93

5.46

1,141,255

Granted

2,422,714

14.49

55.08

Forfeited

506,540

44.32

Exercised

1,333,087

16.59

74,380

Outstanding at December 31, 2023

 

10,191,721

 

16.07

 

62.08

 

4.97

 

517,605

Vested and expected to vest as of December 31, 2023

 

10,191,721

 

16.07

 

62.08

 

4.97

 

517,605

Exercisable as of December 31, 2023

 

5,335,293

 

15.74

 

50.36

 

4.34

 

287,997

Schedule of RSUs classified as equity

    

    

Weighted 

Numbers of

average grant

 RSUs

 date fair value

RMB

Outstanding at January 1, 2023

Granted

 

189,012

 

76.52

Forfeited

 

 

  

Exercised

 

35,691

 

  

Outstanding at December 31, 2023

 

153,321

 

76.06

Vested and expected to vest as of December 31, 2023

 

153,321

 

76.06

Exercisable as of December 31, 2023

 

 

Schedule of share-based compensation for all employee share options, restricted share units and tandem award

    

For the Year ended December 31,

    

2021

    

2022

    

2023

RMB

RMB

RMB

Cost of revenues

    

1,813

    

8,037

    

16,245

Sales and marketing expenses

 

1,488

 

6,291

 

20,682

General and administrative expenses

 

38,892

 

48,998

 

63,326

Research and development expenses

 

12,090

 

41,893

 

134,371

Total

 

54,283

 

105,219

 

234,624